首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan
【24h】

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

机译:发现COPD:一项横断面研究,评估日本COPD的社会经济负担

获取原文
           

摘要

Background: COPD remains a major health problem in Japan. Patients with COPD experience a reduced quality of life (QoL) and have a higher chance of work impairment and productivity loss. However, there is a lack of data on the impact of COPD in terms of QoL and work activity impairment in Japan. This study assessed the socioeconomic burden of COPD in Japan and the impact it may have on the working age population. Patients and methods: This was a 2-year retrospective chart review in COPD patients aged ≥40?years, with at least one health care visit to clinic or hospital in the previous 12?months. Patients were required to have available medical charts for at least the previous 24?months. Symptoms were assessed using COPD assessment test score; EuroQoL Group 5 Dimension (EQ-5D-5L) and work productivity and activity impairment general health questionnaires were used to evaluate health-related QoL and work productivity, and health care resource utilization data were obtained from clinical charts. Results: In total, 71 patients aged 65?years, and 151 patients aged ≥65?years were included; the majority of patients had moderate or severe airflow limitation. Exacerbations (moderate or severe) were reported by ~35% of patients in both age groups; 52.1% and 62.9% of patients in the 65-year and ≥65-year age groups had COPD assessment test scores ≥10. EQ-5D-5L index scores in the 65-year and ≥65-year age groups were 0.79 and 0.77, respectively. Work productivity and activity impairment scores were higher in 65-year age group. Annual costs of health care resource use per patient in the 65-year and ≥65-year age groups were ¥438,975 (US$4,389) and ¥467,871 (US$4,678), respectively. Costs due to productivity loss were estimated to be ¥5,287,024 (US$52,870) in the 65-year age group and ¥3,018,974 (US$30,187) in the ≥65-year age group. Conclusion: COPD represents a significant socioeconomic burden in Japan. Patients with COPD report significant use of health care resources. Higher impact on work impairment and productivity loss was observed frequently in the working age population.
机译:背景:COPD仍然是日本的主要健康问题。患有COPD的患者的生活质量(QoL)降低,工作受损和生产力下降的机会更高。但是,在日本,缺乏有关COPD对生活质量和工作活动损害的影响的数据。这项研究评估了日本COPD的社会经济负担及其对劳动年龄人口的影响。患者和方法:这是对≥40岁的COPD患者进行的为期2年的回顾性图表回顾,在过去的12个月中至少有一次就诊于诊所或医院。要求患者至少在过去24个月内具有可用的病历。使用COPD评估测试评分评估症状;使用EuroQoL第5组维度(EQ-5D-5L)以及工作生产率和活动障碍一般健康调查表评估与健康相关的QoL和工作生产率,并从临床图表中获得医疗资源利用率数据。结果:总共包括71名<65岁的患者和151名≥65岁的患者。大多数患者有中度或重度气流受限。在这两个年龄段中,约有35%的患者报告病情加重(中度或重度); <65岁和65岁以上年龄组的52.1%和62.9%的患者COPD评估测试得分≥10。 <65岁和≥65岁年龄组的EQ-5D-5L指数得分分别为0.79和0.77。 <65岁年龄组的工作效率和活动障碍得分较高。 <65岁和65岁以上年龄组每名患者的年度医疗保健资源使用费用分别为438,975日元(4,389美元)和467,871日元(4,678美元)。在65岁以下的年龄组中,由于生产力损失造成的成本估计为5,287,024日元(52,870美元),在65岁以上的年龄组中,成本为3,018,974日元(30,187美元)。结论:COPD在日本代表了巨大的社会经济负担。 COPD患者报告大量使用卫生保健资源。在劳动年龄人口中,经常观察到对工作障碍和生产率下降的影响更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号